国家医保局：要发挥医保战略购买作用，支持医药产业创新发展

Core Viewpoint - The national medical insurance work conference emphasizes the strategic purchasing role of medical insurance to support the innovative development of the pharmaceutical industry [1] Group 1: Support for Pharmaceutical Industry - The conference aims to guide healthy competition and differentiated innovation within the pharmaceutical industry [1] - Implementation of measures to support the high-quality development of innovative drugs will be prioritized, enhancing the multi-payment capability for innovative drugs [1] Group 2: Drug Procurement and Pricing - New rounds of national drug procurement and high-value medical consumables procurement will be conducted [1] - Continued promotion of national alliance procurement for traditional Chinese medicine and Chinese herbal pieces is planned [1] - The goal is to achieve direct settlement for selected drugs and consumables from national procurement, with a focus on improving enterprise cash flow efficiency [1] Group 3: Price Registration and International Expansion - The Chinese drug price registration system will be utilized to enhance multi-price discovery functions [1] - Efforts will be made to assist the Chinese pharmaceutical industry in expanding internationally [1]